Verified peer comparison
BlackRock ESG Capital Allocation Term Trust vs Vanda Pharmaceuticals Financial Comparison
Direct answer
BlackRock ESG Capital Allocation Term Trust and Vanda Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free BlackRock ESG Capital Allocation Term Trust email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- BlackRock ESG Capital Allocation Term Trust Revenue
- 216,227,545 USD
- Vanda Pharmaceuticals Revenue
- 216,105,000 USD
- BlackRock ESG Capital Allocation Term Trust Operating income
- 213,368,713 USD
- Vanda Pharmaceuticals Operating income
- -151,168,000 USD